Clinical Trial Update: Edwards EVOQUE Eos MISCEND Study [NA]

View source ↗

Summary

Clinical trial update for Edwards Lifesciences' EVOQUE Eos MISCEND study evaluating treatment for mitral valve regurgitation; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Valve Regurgitation (Degenerative or Functional) | NA | Status: ACTIVE_NOT_RECRUITING